Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Mesenchymal Stem Cells for Late-Stage AIDS
NCT05939167Phase 2Recruiting
- Sponsor
- Cell Energy Life Science
- Start
- Dec 2023
- Primary completion
- Jul 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in acquired immunodeficiency syndrome (AIDS), sponsored by Cell Energy Life Science. Started Dec 2023; status: recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on NCT05939167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05939167.